- Home
- KC vs PRCT Comparison
KC vs PRCT Comparison
Compare KC & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KC
- PRCT
- Stock Information
- Founded
- KC 2012
- PRCT 2009
- Country
- KC China
- PRCT United States
- Employees
- KC N/A
- PRCT N/A
- Industry
- KC Computer Software: Prepackaged Software
- PRCT Medical Specialities
- Sector
- KC Technology
- PRCT Health Care
- Exchange
- KC Nasdaq
- PRCT Nasdaq
- Market Cap
- KC 3.2B
- PRCT 3.2B
- IPO Year
- KC 2020
- PRCT 2021
- Fundamental
- Price
- KC $15.80
- PRCT $55.72
- Analyst Decision
- KC Strong Buy
- PRCT Buy
- Analyst Count
- KC 4
- PRCT 8
- Target Price
- KC $9.10
- PRCT $86.14
- AVG Volume (30 Days)
- KC 2.3M
- PRCT 1.0M
- Earning Date
- KC 08-19-2025
- PRCT 08-06-2025
- Dividend Yield
- KC N/A
- PRCT N/A
- EPS Growth
- KC N/A
- PRCT N/A
- EPS
- KC N/A
- PRCT N/A
- Revenue
- KC $1,099,631,090.00
- PRCT $249,121,000.00
- Revenue This Year
- KC $22.76
- PRCT $47.38
- Revenue Next Year
- KC $15.95
- PRCT $31.71
- P/E Ratio
- KC N/A
- PRCT N/A
- Revenue Growth
- KC 14.67
- PRCT 59.36
- 52 Week Low
- KC $2.02
- PRCT $47.04
- 52 Week High
- KC $22.26
- PRCT $103.81
- Technical
- Relative Strength Index (RSI)
- KC 64.98
- PRCT 42.58
- Support Level
- KC $14.78
- PRCT $55.76
- Resistance Level
- KC $16.17
- PRCT $60.57
- Average True Range (ATR)
- KC 0.55
- PRCT 3.08
- MACD
- KC 0.30
- PRCT -0.05
- Stochastic Oscillator
- KC 88.39
- PRCT 42.26
About KC Kingsoft Cloud Holdings Limited
Kingsoft Cloud Holdings Ltd is an independent cloud service provider in China. It provides integrated cloud-based services including cloud computing, storage, and delivery. Its products and services are Security, Database, Data Analysis, Networking, and others. Its solutions are medical, government affairs, finance, media, education, gaming, Vehicle solutions, and others.
About PRCT PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.